WEIKANG BIO-TECHNOLOGY GROUP CO., INC.: key financial figures for fiscal year 2011 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2011): $101.7M
Net Income/Loss (FY2011): $29.6M
Total Assets (FY2011): $123.2M
Total Equity (FY2011): $112.1M
Cash Flows from Operating Activities (FY2011): $30.5M

Source: WEIKANG BIO-TECHNOLOGY GROUP CO., INC. 10-K filing (FY2011). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

WEIKANG BIO-TECHNOLOGY GROUP CO., INC.: key financial figures for fiscal year 2011 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2011): $101.7M
Net Income/Loss (FY2011): $29.6M
Total Assets (FY2011): $123.2M
Total Equity (FY2011): $112.1M
Cash Flows from Operating Activities (FY2011): $30.5M

Source: WEIKANG BIO-TECHNOLOGY GROUP CO., INC. 10-K filing (FY2011). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.